Europe — EMA
Olanzapine Accord
Olanzapine, the active ingredient in Olanzapine Accord, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Accord, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine Accord is used in psychiatric disorders that involve dopamine and serotonin dysregulation.
- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I Disorder (Manic Phase): alleviates acute manic symptoms such as elevated mood, increased activity, and pressured speech. - Bipolar II Disorder (Depressive Phase): used as adjunctive therapy to improve depressive symptoms when other treatments are insufficient. - Schizoaffective disorder: addresses both psychotic and mood components. - Maintenance Therapy: provides …
